Author:
Gänsslen Axel,Schmehl Ingo
Publisher
Springer Berlin Heidelberg
Reference121 articles.
1. Anderson R, Hansson L, Nilsson O, Dijlai-Merzoug R, Settergren G (2001) High serum S100B levels for trauma patients without head injuries. Neurosurgery 48:1255–1258
2. Asken B, Bauer R, DeKosky S, Houck Z, Moreno C, Jaffee M, Dubose D, Boone J, Weber A, Clugston J (2018) Concussion BASICS II: baseline serum biomarkers, head impact exposure, and clinical measures. Neurology 91:e2123–e2132
3. Asken B, Bauer R, DeKosky S, Houck Z, Moreno C, Jaffee M, Weber A, Clugston J (2018) Concussion biomarkers assessed in collegiate student-athletes (BASICS) I: normative study. Neurology 91:e2109–e2122
4. Asken B, Bauer R, DeKosky S, Svingos A, Hromas G, Boone J, DuBose D, Hayes R, Clugston J (2018) Concussion BASICS III: serum biomarker changes following sport-related concussion. Neurology 91:e2133–e2143
5. Ayaz S, Lewis L, Unden J, Chen J, Mika V, Saville B, Tyndall J, Nash M, Buki A, Barzo P, Hack D, Tortella F, Schmid K, Hayes R, Vossough A, Sweriduk S, Bazarian J (2016) Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neurotrauma 33:203–214